Study: NCT03386721

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: simlukafusp alfa
Description: simlukafusp alfa will be administered as per the dosage regimen mentioned in arm descriptions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: simlukafusp alfa
Description: simlukafusp alfa will be administered as per the dosage regimen mentioned in arm descriptions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: simlukafusp alfa
Description: simlukafusp alfa will be administered as per the dosage regimen mentioned in arm descriptions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: simlukafusp alfa
Description: simlukafusp alfa will be administered as per the dosage regimen mentioned in arm descriptions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: simlukafusp alfa
Description: simlukafusp alfa will be administered as per the dosage regimen mentioned in arm descriptions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: simlukafusp alfa
Description: simlukafusp alfa will be administered as per the dosage regimen mentioned in arm descriptions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: simlukafusp alfa
Description: simlukafusp alfa will be administered as per the dosage regimen mentioned in arm descriptions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: simlukafusp alfa
Description: simlukafusp alfa will be administered as per the dosage regimen mentioned in arm descriptions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: simlukafusp alfa
Description: simlukafusp alfa will be administered as per the dosage regimen mentioned in arm descriptions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: simlukafusp alfa
Description: simlukafusp alfa will be administered as per the dosage regimen mentioned in arm descriptions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: simlukafusp alfa
Description: simlukafusp alfa will be administered as per the dosage regimen mentioned in arm descriptions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: simlukafusp alfa
Description: simlukafusp alfa will be administered as per the dosage regimen mentioned in arm descriptions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: simlukafusp alfa
Description: simlukafusp alfa will be administered as per the dosage regimen mentioned in arm descriptions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: simlukafusp alfa
Description: simlukafusp alfa will be administered as per the dosage regimen mentioned in arm descriptions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: simlukafusp alfa
Description: simlukafusp alfa will be administered as per the dosage regimen mentioned in arm descriptions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: simlukafusp alfa
Description: simlukafusp alfa will be administered as per the dosage regimen mentioned in arm descriptions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atezolizumab (MPDL3280A), an Engineered Anti-PD-L1 Antibody
Description: Atezolizumab will be administered as per the dosage regimen mentioned in arm descriptions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atezolizumab (MPDL3280A), an Engineered Anti-PD-L1 Antibody
Description: Atezolizumab will be administered as per the dosage regimen mentioned in arm descriptions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atezolizumab (MPDL3280A), an Engineered Anti-PD-L1 Antibody
Description: Atezolizumab will be administered as per the dosage regimen mentioned in arm descriptions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atezolizumab (MPDL3280A), an Engineered Anti-PD-L1 Antibody
Description: Atezolizumab will be administered as per the dosage regimen mentioned in arm descriptions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atezolizumab (MPDL3280A), an Engineered Anti-PD-L1 Antibody
Description: Atezolizumab will be administered as per the dosage regimen mentioned in arm descriptions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atezolizumab (MPDL3280A), an Engineered Anti-PD-L1 Antibody
Description: Atezolizumab will be administered as per the dosage regimen mentioned in arm descriptions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atezolizumab (MPDL3280A), an Engineered Anti-PD-L1 Antibody
Description: Atezolizumab will be administered as per the dosage regimen mentioned in arm descriptions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atezolizumab (MPDL3280A), an Engineered Anti-PD-L1 Antibody
Description: Atezolizumab will be administered as per the dosage regimen mentioned in arm descriptions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atezolizumab (MPDL3280A), an Engineered Anti-PD-L1 Antibody
Description: Atezolizumab will be administered as per the dosage regimen mentioned in arm descriptions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atezolizumab (MPDL3280A), an Engineered Anti-PD-L1 Antibody
Description: Atezolizumab will be administered as per the dosage regimen mentioned in arm descriptions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atezolizumab (MPDL3280A), an Engineered Anti-PD-L1 Antibody
Description: Atezolizumab will be administered as per the dosage regimen mentioned in arm descriptions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atezolizumab (MPDL3280A), an Engineered Anti-PD-L1 Antibody
Description: Atezolizumab will be administered as per the dosage regimen mentioned in arm descriptions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atezolizumab (MPDL3280A), an Engineered Anti-PD-L1 Antibody
Description: Atezolizumab will be administered as per the dosage regimen mentioned in arm descriptions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atezolizumab (MPDL3280A), an Engineered Anti-PD-L1 Antibody
Description: Atezolizumab will be administered as per the dosage regimen mentioned in arm descriptions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atezolizumab (MPDL3280A), an Engineered Anti-PD-L1 Antibody
Description: Atezolizumab will be administered as per the dosage regimen mentioned in arm descriptions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atezolizumab (MPDL3280A), an Engineered Anti-PD-L1 Antibody
Description: Atezolizumab will be administered as per the dosage regimen mentioned in arm descriptions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: Single-agent treatment administered as per approved protocol.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vinorelbine
Description: Single-agent treatment administered as per approved protocol.